A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


https://www.docwirenews.com/condition-center/multiple-sclerosis-knowledge-hub/a-phase-ii-clinical-trial-with-repeated-intrathecal-injections-of-autologous-mesenchymal-stem-cells-in-patients-with-amyotrophic-lateral-sclerosis/

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.